The use of lisuride as initial antiparkinsonian medication for Parkinson's disease has been advocated, delaying the need for levodopa until lisuride becomes insufficient for controlling the parkinsonian symptoms.
This passage describes a strategy for managing Parkinson's disease using lisuride as a first-line treatment to delay the need for levodopa.